Results 211 to 220 of about 3,932,256 (404)

Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background The role of the general practice pharmacist (GPP) in Australia is not yet clearly defined, and their clinical expertise remains underutilised in general practice settings. This may be attributed to a limited understanding of pharmacists' capabilities, which can hinder optimal GPP utilisation.
Christel Chandra, Brooke Bevis, Nazanin Falconer, Holly Foot   +3 more
wiley   +1 more source

Antihypertensive Drug Treatment [PDF]

, 1996

openalex   +1 more source

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih, Ming‐Lun Yeh, Yi‐Hung Lin, Ping‐Tsung Shih, Kuan‐Ta Wu, Meng‐Hsuan Hsieh, Jeng‐Fu Yang, Yi‐Yu Chen, Po‐Cheng Liang, Yu‐Ju Wei, Pei‐Chien Tsai, Ya‐Yun Cheng, Ming‐Yen Hsieh, Chih‐Wen Wang, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Chi‐Kung Ho, Wan‐Long Chuang, Vincent Wai‐Sun Wong, Wei‐Ting Chang, Ming‐Lung Yu   +21 more
wiley   +1 more source

Predictors of Antihypertensive Drug Adherence and Blood Pressure Control Among Hypertensive Patients: A Multicenter Cross-Sectional Study. [PDF]

Int J Hypertens
Elias TP, Minyilshewa AT, Tekle MA, Gebreamlak TW, Adde BL.   +4 more
europepmc   +1 more source

Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies. [PDF]

BMC Med Res Methodol, 2023
Arisido MW, Foco L, Shoemaker R, Melotti R, Delles C, Gögele M, Barolo S, Baron S, Azizi M, Dominiczak AF, Zennaro MC, P Pramstaller P, Poglitsch M, Pattaro C.   +13 more
europepmc   +1 more source

Resistant hypertension and renal denervation: Who's kidding whom? [PDF]

, 2014
Sever, P
core   +1 more source

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population [PDF]

, 1995
Judith K. Jones, Larry Gorkin, Jean Lian, Judy A. Staffa, A. Fletcher   +4 more
openalex   +1 more source

Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang, Jian‐Chih Chen, Sung‐Yen Lin, Kun‐Der Lin, Pei‐Shan Ho, Chung‐Hwan Chen, Yin‐Chih Fu, Tien‐Ching Lee   +7 more
wiley   +1 more source

Non-persistence to antihypertensive drug therapy in Lithuania. [PDF]

Eur J Clin Pharmacol, 2022
Treciokiene I, Bratcikoviene N, Gulbinovic J, Wettermark B, Taxis K.   +4 more
europepmc   +1 more source

Lessons from Antihypertensive Drug Trials That Employed ???Stepped Care???

, 1984
John H. Laragh
openalex   +1 more source